Polyrizon Ltd. (PLRZ) Stock Ticker
Market factors today
Unlock the full PLRZ picture
About Polyrizon Ltd.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
PLRZ stock facts
| Ticker symbol | PLRZ |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $12.1M |
| CEO | Tomer Izraeli |
| Employees | 6 |
| Headquarters | Ra'anana, TA, IL |
| IPO date | 2024-10-29 |
| Website | www.polyrizon-biotech.com |
What you can see for PLRZ on Tickr
Live PLRZ price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PLRZ report.
Rankings
FAQ
What is the ticker symbol for Polyrizon Ltd.?
The ticker symbol for Polyrizon Ltd. is PLRZ, listed on the NASDAQ Global Market.
What is PLRZ?
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14,…